Published Date: 03 Sep 2026
OnabotulinumtoxinA reduces headache days and resolves medication overuse in patients with chronic migraine and multiple prior preventive treatment failures.
Read Full NewsPhase 2a trial results showed 800 mg vutiglabridin significantly improved motor symptom scores compared with placebo in early-stage Parkinson's disease.
Carlos Cruchaga, PhD, director of the NeuroGenomics and Informatics Center at Washington University, discusses emerging blood-based biomarkers for monitoring biological and cognitive responses to lecanemab treatment in Alzheimer disease.
Christen Kutz, PhD, PA-C, discusses a retrospective survey of neurology providers examining why patients with generalized myasthenia gravis are transitioning to nipocalimab and what real-world outcomes data suggest about its role in the treatment landscape.
Mitzi Joi Williams, MD, is joined by Jakai McEwen, DO, and Charnetta Colton-Poole, MD, to discuss the challenges of communication between patients and their health care teams, including navigating medical language, promoting shared decision-making, and advocating for clear, patient-centered care.
An MDS 2026 plenary speaker discusses the evolving role of infusion therapies, deep brain stimulation, and focused ultrasound in Parkinson disease, including when to consider device-aided therapies and how treatment selection can be individualized.
A survey of patients with IgA nephropathy shows how nonspecific symptoms and long referral waits delay diagnosis by up to two years.
Lozach outlines how the Corticosteroid Stewardship Alliance plans to bring clinician data and adverse event costs to payers and lawmakers.
1.
In cancer survivors, loneliness is associated with a higher risk of death.
2.
I Watched My Friend Choose Death. Physician-Assisted Suicide Needs More Guardrails.
3.
Indoor hydroponic gardening can improve mental health and quality of life for cancer patients
4.
In prostate cancer survivorship, sleep disturbances are underappreciated.
5.
New Gene Therapy Nears EU Nod for Bladder Cancer
1.
Bone Marrow Niche Remodeling in Hematologic Dysfunction
2.
Targeted Therapies for Breast Cancer: What’s New?
3.
Revolutionizing Cancer Care: The Impact of Darzalex Faspro
4.
Interpreting Iron Studies: What Your Blood Results Really Mean
5.
Liquid Biopsy in Oncology: Innovations in Cancer Detection, Monitoring, and Clinical Use
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
2.
The Role of Platelets in Normal Blood Clotting
3.
Understanding Common Causes of Abnormal Blood Counts
4.
Understanding Blood Disorders and Their Diagnosis
5.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation